Literature DB >> 6165113

Renal allograft rejection associated with presensitization to HLA-DR antigens.

T Mohanakumar, C Rhodes, G Mendez-Picon, M Goldman, C Moncure, H Lee.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 6165113     DOI： 10.1097/00007890-198101000-00023

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  4 in total

1.  Preformed lymphocytotoxic antibodies: the effects of class, titer and specificity on liver vs. heart allografts.

Authors:  T Furuya; N Murase; K Nakamura; J Woo; S Todo; A J Demetris; T E Starzl
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

2.  Marked mitigation of transplant vascular sclerosis in FasLgld (CD95L) mutant recipients. The role of alloantibodies in the development of chronic rejection.

Authors:  V Subbotin; H Sun; A Aitouche; A Salam; L A Valdivia; J J Fung; T E Starzl; A S Rao
Journal:  Transplantation       Date:  1999-05-27       Impact factor: 4.939

3.  HLA-antibody testing: the immune phagocytosis inhibition test is superior to the PRA-STAT and NIH lymphocytotoxic test with respect to specificity.

Authors:  B K Flesch; M Philipp; U Cassens; J Neppert
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

4.  HLA-DR, and not PLA2R, is expressed on the podocytes in kidney allografts in de novo membranous nephropathy.

Authors:  Jiqiu Wen; Kenan Xie; Mingchao Zhang; Jinsong Chen; Jiong Zhang; Dongrui Cheng; Xue Li; Shuming Ji; Zhihong Liu
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.